Moat Ross
CHIEF OPERATING OFFICER · 14 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 1,703 | $46.69 | $79,513.07 | filing |
| 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 774 | $48.94 | $37,879.56 | filing |
| 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,477 | — | — | filing |
| 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 2,367 | $48.58 | $114,988.86 | filing |
| 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 1,706 | $48.13 | $82,109.78 | filing |
| 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 5,808 | — | — | filing |
| 2026-01-15 | KNSA | Kiniksa Pharmaceuticals International, plc | Award | 879 | $24.16 | $21,236.64 | filing |
| 2025-09-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 3,523 | $35.31 | $124,397.13 | filing |
| 2025-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 481 | $34.28 | $16,488.68 | filing |
| 2025-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 994 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 2,819 | $33.49 | $94,408.31 | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 1,741 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 1,611 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,477 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.